ImmuPharma Plc
(LSE) IMM
ImmuPharma Plc Financials at a Glance
Market Cap
$2.49B
Revenue (TTM)
$0.00
Net Income (TTM)
$3.93M
EPS (TTM)
$-0.89
P/E Ratio
-5.56
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Price
$4.95
Volume
3,577,524
Open
$5.10
Price
$4.95
Volume
3,577,524
Open
$5.10
Previous Close
$4.95
Daily Range
$4.91 - $5.60
52-Week Range
$1.39 - $19.33
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Price
$4.95
Volume
3,577,524
Open
$5.10
Previous Close
$4.95
Daily Range
$4.91 - $5.60
52-Week Range
$1.39 - $19.33
IMM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ImmuPharma Plc
Industry
Pharmaceuticals
Sector
Health CareCEO
Tim McCarthy McCarthy, MBA
Website
www.immupharma.comHeadquarters
London, EC1A 7BL, GB
IMM Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-260%
Return on Capital
-10%
Return on Assets
-2%
Earnings Yield
-17.99%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.49B
Shares Outstanding
502.72M
Volume
3.58M
Short Interest
0.00%
Avg. Volume
3.05M
Financials (TTM)
Gross Profit
$63.88K
Operating Income
$2.28M
EBITDA
$2.61M
Operating Cash Flow
$1.77M
Capital Expenditure
$1.65K
Free Cash Flow
$1.77M
Cash & ST Invst.
$236.90K
Total Debt
$0.00
ImmuPharma Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$28.52K
-51.4%
Gross Margin
0.00%
N/A
Market Cap
$2.49B
N/A
Market Cap/Employee
$497.70M
N/A
Employees
5
N/A
Net Income
$919.44K
-373.9%
EBITDA
$600.65K
-4.9%
Quarterly Fundamentals
Net Cash
$396.65K
-63.4%
Accounts Receivable
$155.37K
-55.4%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.83%
N/A
Return on Invested Capital
-10.00%
N/A
Free Cash Flow
$502.57K
-14.6%
Operating Cash Flow
$502.57K
-14.6%